UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

Linear analysis of parameters in Arrhenius model for Ti-6Al-4V at superplastic forming

Engineering computations, 2021-07, Vol.38 (6), p.2528-2551

2021

Volltextzugriff (PDF)

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

PloS one, 2022-10, Vol.17 (10), p.e0276047-e0276047

2022

Volltextzugriff (PDF)

The simple hyperbolic-sine equation for superplastic deformation and parameters optimization

Journal of materials research and technology, 2020-09, Vol.9 (5), p.10819-10829

2020

Volltextzugriff (PDF)

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Haematologica (Roma), 2021-11, Vol.106 (11), p.2927

2021

Volltextzugriff (PDF)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth

Cancers, 2023-07, Vol.15 (14), p.3559

2023

Volltextzugriff (PDF)

1147-B Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 2), p.A1836-A1836

2023

Volltextzugriff (PDF)

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo

Journal of biology (London, England), 2006, Vol.5 (7), p.22-22

2006

Volltextzugriff (PDF)

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

Journal of biology (London, England), 2008, Vol.7 (4), p.12-12

2008

Volltextzugriff (PDF)

Investigation of flow behavior and microstructure of Ti–6Al–4V with annealing treatment during superplastic forming

Materials science & engineering. A, Structural materials : properties, microstructure and processing, 2020-10, Vol.797, p.140046, Article 140046

2020

Volltextzugriff (PDF)

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

JNCI : Journal of the National Cancer Institute, 2019-11, Vol.111 (11), p.1216-1227

2019

Volltextzugriff (PDF)

Abstract 3848: In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinincal models: A report from the Pediatric Preclinical Testing Consortium (PPTC)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3848-3848

2019

Volltextzugriff (PDF)

Abstract 3955: The role of the Wnt/Beta-catenin pathway in adrenocortical carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3955-3955

2020

Volltextzugriff (PDF)

Preclinical efficacy of the Wnt/[beta]-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

PloS one, 2022-10, Vol.17 (10), p.e0276047

2022

Volltextzugriff (PDF)

In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC)

Pediatric blood & cancer, 2021-11, Vol.68 (11), p.e29304-n/a

2021

Volltextzugriff (PDF)

Abstract 3186: Tegavivint suppresses progression and metastasis of osteosarcoma via blockade of Wnt signaling/ALDH1 axis: Preclinical study of a novel Wnt/β-catenin pathway inhibitor

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3186-3186

2018

Volltextzugriff (PDF)

MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells

The Journal of neuroscience, 2013-09, Vol.33 (38), p.15069-15074

2013

Volltextzugriff (PDF)

Abstract LB245: ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB245-LB245

2023

Volltextzugriff (PDF)

IMMU-19. LSD1 MODULATES NK CELL IMMUNOTHERAPY THROUGH AN ONCO-IMMUNOGENIC GENE SIGNATURE IN DIPG

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i102-i102

2018

Volltextzugriff (PDF)

THER-31. TARGETING THE HISTONE DEMETHYLASE LSD1 FOR SELECTIVE APOPTOSIS AND IMMUNE-SENSITIZATION IN PEDIATRIC DIPG

Neuro-oncology (Charlottesville, Va.), 2019-04, Vol.21 (Supplement_2), p.ii120-ii120

2019

Volltextzugriff (PDF)

THER-31. TARGETING THE HISTONE DEMETHYLASE LSD1 FOR SELECTIVE APOPTOSIS AND IMMUNE-SENSITIZATION IN PEDIATRIC DIPG

Neuro-oncology (Charlottesville, Va.), 2019-04, Vol.21 (Supplement_2), p.ii120-ii120

2019

Volltextzugriff (PDF)

Abstract LB001: Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB001-LB001

2023

Volltextzugriff (PDF)

Abstract 815: Improved tolerability and tumor specific delivery of a therapeutic bispecific T cell engager using a pH-sensitive nanoparticle platform

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.815-815

2023

Volltextzugriff (PDF)

Abstract 4234: ONM-501: A polyvalent STING agonist for oncology immunotherapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.4234-4234

2022

Volltextzugriff (PDF)

1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A1198-A1198

2022

Volltextzugriff (PDF)

Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment

Free radical biology & medicine, 2015-02, Vol.79, p.300-323

2015

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Englisch
(88)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(8)
Molecules
(5)
Molecules/molecules Online/molecules Annual
(5)
Neuro-Oncology
(3)
Plos One
(3)
Frontiers In Microbiology
(2)
Journal For Immunotherapy Of Cancer
(2)
Journal Of Biology
(2)
Acs Omega
(1)
Agriculture
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Linear analysis of parameters in Arrhenius model for Ti-6Al-4V at superplastic forming

Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

The simple hyperbolic-sine equation for superplastic deformation and parameters optimization

Transducin β-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth

1147-B Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

Investigation of flow behavior and microstructure of Ti–6Al–4V with annealing treatment during superplastic forming

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

Abstract 3848: In vivo evaluation of the LSD1 inhibitor SP-2577 against Ewing sarcoma and rhabdomyosarcoma preclinincal models: A report from the Pediatric Preclinical Testing Consortium (PPTC)

Abstract 3955: The role of the Wnt/Beta-catenin pathway in adrenocortical carcinoma

Preclinical efficacy of the Wnt/[beta]-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors

In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC)

Abstract 3186: Tegavivint suppresses progression and metastasis of osteosarcoma via blockade of Wnt signaling/ALDH1 axis: Preclinical study of a novel Wnt/β-catenin pathway inhibitor

MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells

Abstract LB245: ONM-501, a dual-activating polyvalent STING agonist, enhances tumor retention and demonstrates favorable preclinical safety profile

IMMU-19. LSD1 MODULATES NK CELL IMMUNOTHERAPY THROUGH AN ONCO-IMMUNOGENIC GENE SIGNATURE IN DIPG

THER-31. TARGETING THE HISTONE DEMETHYLASE LSD1 FOR SELECTIVE APOPTOSIS AND IMMUNE-SENSITIZATION IN PEDIATRIC DIPG

THER-31. TARGETING THE HISTONE DEMETHYLASE LSD1 FOR SELECTIVE APOPTOSIS AND IMMUNE-SENSITIZATION IN PEDIATRIC DIPG

Abstract LB001: Encapsulation of IL-12 with an ultra pH-sensitive nanoparticle platform improves tolerability and promotes antitumor response in mice

Abstract 815: Improved tolerability and tumor specific delivery of a therapeutic bispecific T cell engager using a pH-sensitive nanoparticle platform

Abstract 4234: ONM-501: A polyvalent STING agonist for oncology immunotherapy

1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates

Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment

Suchergebnisse filtern